Michael Schlenk

Chief Executive Officer at curasan AG

Michael Schlenk

Michael Schlenk

Chief Executive Officer at curasan AG

Overview
Career Highlights

curasan AG
ProBioGen AG

RelSci Relationships

419

Number of Boards

3

Relationships
RelSci Relationships are individuals Michael Schlenk likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at curasan AG

Relationship likelihood: Strong

Head-Corporate Communications at curasan AG

Relationship likelihood: Strong

Head-Marketing & Sales at curasan AG

Relationship likelihood: Strong

Founder at curasan AG

Relationship likelihood: Strong

Co-Founder at OXID eSales AG

Relationship likelihood: Strong

Chief Executive Officer at Dr. Wilke Management & Consulting GmbH

Relationship likelihood: Strong

Chief Executive Officer at Pflüger Schulz Rogalla Unternehmensberatung GmbH

Relationship likelihood: Strong

Former Mitglied des Vorstands at Software AG

Relationship likelihood: Strong

Partner at DPE Deutsche Private Equity GmbH

Relationship likelihood: Strong

Partner at Partners för Utvecklingsinvesteringar inom Life Sciences AB

Relationship likelihood: Strong

Paths to Michael Schlenk
Potential Connections via
Relationship Science
You
Michael Schlenk
Chief Executive Officer at curasan AG
Education

We are one of the oldest university-based business schools in the UK, offering management education at undergraduate, masters, MBA, Executive Education and PhD/DBA levels for the past 50 years. One of only 59 business schools across the world with the coveted “Triple Crown” of accreditations, we are ranked amongst the world’s top business schools, have an international staff, alumni and student body and global campus.

Career History
Chief Executive Officer
2014 - Current

curasan AG engages in the developing, manufacturing, and marketing of regenerative medicine. Its products cover the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company was founded by Hans Dieter Rössler in 1988 and is headquartered in Aschaffenburg, Germany.

Chief Executive Officer
2003 - 2010

ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany.

Head-Sales & Marketing
Prior

Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Boards & Committees
Chairman-Supervisory Board
Current

OXID eSales AG provides e-commerce software solutions and services. It offers commercial open source shopping cart software and integrates all touchpoints such as webshop, mobile, and point of sale. The firm also provides professional services from strategy development and project implementation to operation of a successful multi-channel business. The company was founded by Andrea Seeger, Roland Fesenmayr and Eric Jankowfsky in 2003 and is headquartered in Freiburg, Germany.

Member-Supervisory Board
Current

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Member, Managing Board
Current

curasan AG engages in the developing, manufacturing, and marketing of regenerative medicine. Its products cover the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company was founded by Hans Dieter Rössler in 1988 and is headquartered in Aschaffenburg, Germany.

Advisors
Advisor

Founder at curasan AG

Other Affiliations

Michael Schlenk is affiliated with curasan AG, ProBioGen AG, Novartis AG, OXID eSales AG, Centogene AG, curasan AG